Truly Personalized Medicine?
The patient wished to receive an experimental drug that she was instrumental in developing. After her diagnosis, she had investigated treatments that might help her condition and discovered that a specific compound could be beneficial. To further the development of this potential drug, she obtained...
| Authors: | ; ; |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Interlibrary Loan: | Interlibrary Loan for the Fachinformationsdienste (Specialized Information Services in Germany) |
| Published: |
2014
|
| In: |
The Hastings Center report
Year: 2014, Volume: 44, Issue: 4, Pages: 11-12 |
| Online Access: |
Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |
MARC
| LEADER | 00000naa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1937534065 | ||
| 003 | DE-627 | ||
| 005 | 20251002055623.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 251002s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/hast.325 |2 doi | |
| 035 | |a (DE-627)1937534065 | ||
| 035 | |a (DE-599)KXP1937534065 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 1 |2 ssgn | ||
| 100 | 1 | |a Smith, Lauren B. |e VerfasserIn |4 aut | |
| 245 | 1 | 0 | |a Truly Personalized Medicine? |
| 264 | 1 | |c 2014 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The patient wished to receive an experimental drug that she was instrumental in developing. After her diagnosis, she had investigated treatments that might help her condition and discovered that a specific compound could be beneficial. To further the development of this potential drug, she obtained preclinical data, founded a company, and sought investment from venture capitalists. The company was about to begin phase I testing, but the clinical trial had not yet opened. In addition, she would not have been a candidate for the study, as it excluded patients with advanced disease. To be able to administer this drug to her, the patient's team of oncologists was in the process of drafting an individual patient investigational new drug application, including the protocol for the drug's delivery, to the Food and Drug Administration. The company developing the drug had preliminarily agreed to provide it. This protocol was also under review by the institutional review board of the university, and the ethics committee was consulted to determine whether she should receive the drug. | ||
| 700 | 1 | |a Cooke, Colin R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Goldman, Edward B. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |a Hastings Center |t The Hastings Center report |d Malden, Mass. : Wiley, 1971 |g 44(2014), 4, Seite 11-12 |h Online-Ressource |w (DE-627)341346551 |w (DE-600)2067369-3 |w (DE-576)258761822 |x 1552-146X |7 nnas |
| 773 | 1 | 8 | |g volume:44 |g year:2014 |g number:4 |g pages:11-12 |
| 856 | 4 | 0 | |u https://doi.org/10.1002/hast.325 |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1002/hast.325 |x Verlag |z lizenzpflichtig |3 Volltext |
| 912 | |a NOMM | ||
| 935 | |a mteo | ||
| 951 | |a AR | ||
| ELC | |a 1 | ||
| ITA | |a 1 |t 1 | ||
| LOK | |0 000 xxxxxcx a22 zn 4500 | ||
| LOK | |0 001 4779660246 | ||
| LOK | |0 003 DE-627 | ||
| LOK | |0 004 1937534065 | ||
| LOK | |0 005 20251002055623 | ||
| LOK | |0 008 251002||||||||||||||||ger||||||| | ||
| LOK | |0 035 |a (DE-Tue135)IxTheo#2025-09-26#679BCC6DF51CCF77E229B5C05A2C97A44E9FAC8D | ||
| LOK | |0 040 |a DE-Tue135 |c DE-627 |d DE-Tue135 | ||
| LOK | |0 092 |o n | ||
| LOK | |0 852 |a DE-Tue135 | ||
| LOK | |0 852 1 |9 00 | ||
| LOK | |0 935 |a ixrk |a ixzs |a zota |a tiep | ||
| ORI | |a TA-MARC-ixtheoa001.raw | ||
